SupremePharmaceuticalsLogoTSXV: FIRE

Supreme Pharmaceuticals Inc. has announced exciting changes and additions to their  senior leadership team as the Company prepares for growth.

“Our business is driven by a commitment to quality. The quality of our products, the quality of our facility and most of all: the quality of our leadership team.”

-John Fowler, CEO of Supreme.

 

Navdeep Dhaliwal appointed President of Supreme

Mr. Navdeep Dhaliwal has been appointed President of Supreme after serving as Chief Financial Officer during the first stage of the Company’s development. Mr. Dhaliwal will focus on capital markets, international growth and strategic initiatives such as investments and acquisitions.

Omer Azeez appointed VP Marketing & Regulatory Affairs

Mr. Omer Azeez has been appointed Vice President, Marketing & Regulatory Affairs. Mr. Azeez brings over 18 years of domestic and international marketing experience in highly government-regulated markets from his tenure at Philip Morris International. Mr. Azeez’s track record of developing award-winning strategic initiatives targeting consumer and enterprise audiences strengthens Supreme’s wholesale distribution strategy.

“I am excited to join the dynamic leadership team at Supreme and look forward to adding immediate value by leveraging my experience to establish our wholesale distribution models and long term marketing strategy.”

-Mr. Azeez, Vice President, Marketing & Regulatory Affairs of Supreme.

Dimitre Naoumov appointed Chief Financial Officer

Supreme is pleased to announce the appointment of Mr. Dimitre Naoumov, CPA, CA as Chief Financial Officer.  Mr. Naoumov has spent nine years at KPMG LLP where he quickly rose to Senior Manager and a key member of the Technology, Media and Telecommunications practice based out of Toronto, Canada. Mr. Naoumov assisted some of Canada’s largest and most respected public companies with financial reporting, regulatory compliance and corporate transactions. Mr. Naoumov also has extensive experience helping small cap companies during the growth stage with corporate governance, disclosure and accounting best practices.

“Since inception, we have focused on developing 7ACRES into a platform for cultivating high-quality cannabis at scale.  Now that we have commenced commercial sales of our high-quality cannabis, we are preparing to accelerate our domestic and international growth initiatives. Ensuring that we have the right leadership and human resources is critical to supporting those growth initiatives.”

-John Fowler, CEO of Supreme.

Supreme anticipates the changes and additions to its leadership team will take effect by the end of October of this year.

 

Grant of Stock Options

In addition to the aforementioned leadership changes, the Company granted 3,005,000 stock options (each an “Option“) to various employees, directors and consultants pursuant to the Company’s Employee Stock Option Plan (the “Plan“).  Each Option has an exercise price of $1.45 and is exercisable at any time prior to September 25, 2022, subject to the terms and conditions of the Plan.